Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes I Agree!
Also why would they bother to file an Extension in the first place if they had no intention of becoming current?
Here's the language of the SEC Extension request:
The subject annual report, semi-annual report, transition report on Forms 10-K, 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day followingthe prescribed due date.
So based on this language they have up to 15 Calendar days AFTER the 9/28/21 deadline to file! Therefore they have Six Weeks from now to become current.
So again the question begs why did they waste their time, energy, and expense to file an Extension if they have no intention of becoming current???
Why not just "forget about it" and ALSO NOT respond to any eMails??
Everyone knows that most of not all Fraudsters go DARK with ZERO communication in order to make a clean get away!
Not only this, the email response sent to me would be extremely incriminating in a Class Action Law Suit for reason it corroborates "Intent to Commit Fraud" AND the person who sent me that eMail could be viewed as being complicit in the commission of Securities Fraud a crime that historically people have been sent to prison for. It is a Federal Crime that essentially would ruin the persons involved for life!
Lot's of High Risk liability this company faces if they don't become current within the time frame indicated in that SEC filing.
Time will tell...
Response From VBHI Regarding Becoming SEC Compliant!
Ok everyone I GOT an eMail Response from VBHI yesterday 9/3/21!
Here's what they said in response of me posing the question of why it's taking so long to get SEC Current in the face of the fast approaching September 28, 2021 deadline.
I stated to them the following in my eMail:
"It's only reasonable to let your investors know what's going on with becoming SEC Current before the September 28, 2021 deadline and if you don't perceive that will happen OR VBHI is going defunct, you should have the courtesy to inform us so we can cut our losses and move on."
Here's their reply:
"We continue the work necessary for filing. We are planning to file as soon as practically possible."
Paul Knopick
If You're New To This Message Board This is For You
RGBP Will Exceed ENCZ's 0.95 run in February: Target: $1.50-$3.00
WHY?
ENZC had
#1 (1) Patent only
#2 No FDA approval
#3 No licensing arrangements
#4 No partnerships
#5 No catalysts
#6 No PR releases
#7 No prospect of revenue (due to #2 & #3)
#8 No suggestion of Buy Out by CEO
RGBP has
#1 (24) Patents worth $BILLIONS$
https://patents.google.com/?inventor=David+Koos&sort=new
#2 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine "The Future of Medicine"
Notice the Big Pharma Industry drive to develop mRNA Vaccines for treating cancer; a Trillion Dollar Market!
https://www.ventureradar.com/keyword/Cancer%20Vaccines
#3 FDA Approved Patent for Clinical Trials
https://newsinvasion24.com/regen-biopharma-inc-otcmkts-rgbp-gets-approval-for-cancer-vaccine-patent/
#4 Partnership:Paid $1.1 Million by Oncology Pharma for Patent Licensing: Now Positioned to Post Quarterly Revenues for 15 YEARS!
(This is indicative of a NASDAQ Stock unlike any OTC)
#5 Pink Current - World Wide Buying IN PROGRESS!
#6 CEO suggests Buy Out:Filed 8K 4/27/21 to prevent Hostile Take Over that says "parties seeking to ACQUIRE must negotiate directly."
https://www.otcmarkets.com/filing/conv_pdf?id=14894907&guid=YIu9knc_n0y8Rth
#7 Big Pharmas Identified to Acquire RGBP in a possible Bidding WAR
https://www.reddit.com/r/RGBP/comments/pec4xa/rgbp_buy_out_bidding_war/
BONUS
Informative Video on RGBP & The OTC Biopharma Sector:
Thank You!
Thanks! By Any Chance Do You....
...have a link for both of those sources. I'm not sure the link I have is the most current one!
Thank you in advance for your assistance.
Also what is "WO?"
Thanks!
Would Like To Know Everyone's Take On...
The Patent Count History on RGBP
My understanding is it's 24
https://patents.google.com/?inventor=David+Koos&sort=new
Thanks
Closed UP 28% On 516 Billion Trade Volume & 22.8 Million Dollar Volume!
This speaks for itself in terms of the massive interest in this stock AND it's only the 2nd Day Post Pink Current!
Enough Said, and just think the full impact of World Wide Buy Volume will not set in substantially for at least another TWO Weeks!
Be well and prosper...
F.Y.I. It took 19 Trading Days POST PINK CURRENT for ENZC to make it's run to 0.95
How misinformed you are!
NO BIGGIE! Sell News - Buy Rumor!
PINK CURRENT I would say qualifies as BIG NEWS!!
....with nearly a Half Billion in Volume to BOOT!
Added HEAVILY on the Pull Back!
Be well and prosper...
RGBP Buy Out Bidding WAR!
I strongly believe RGBP will be acquired between $5.75 to $6.25 per Share (i.e. $21.7 Billion to $23.6 Billion) in a "Bidding War" involving several Big Pharmas.
Here's the Short List of those Companies I previously identified:
#1 Gilead Sciences
#2 Precigen
#3 Pfizer
#4 Moderna
#5 BioNTech
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165627226
WHY?
It's important to recognize that based on Gilead's Sciences acquisition of Kite Pharma in 2017 it was based entirely on the mRNA Cancer Vaccine Patent Kite developed relative to its future global market potential when little was known about mRNA Biotechnology unlike today every Big Pharma in the Industry knows about it and is highly motivated to carve out a piece of that TRILLION DOLLAR MARKET in order to remain competitive in the rapidly advancing pharmaceutical landscape that's on the brink of radical transformation in medical therapeutics that will define the future of medicine! I have also previously discussed this at length.
It's things like this that catch most investors off guard like in the early days of Microsoft, Apple Computers, Amazon, etc., etc, when very little was known about these companies during their formative years when ALL of them were off everyone's radar!
Each one of them had one thing in common, they caused a fundamental shift in global society that re-defined the way people live. A complete transformation of society.
Kite Pharma did that via the Gilead Acquisition that brought the mRNA Vaccine Biotechnology front center stage to the Main Stream Pharmaceutical Industry and look where we are today with the mRNA Vaccine going GLOBAL to combat Covid-19.
This resulted in companies like Pfizer & Moderna mass producing and distributing the Covid Vaccine world wide that resulted in increasing their market revenues exponentially and protecting hundreds of millions of people from the effects of Covid-19.
The ONLY reason there was NOT a Big Pharma Bidding War over Kite Biopharma in 2017 was very little was known at that time about mRNA Bioscience that has to do with instructing cells in the human body to build immunity to the virus genome. The mRNA Vaccine "teaches" cells in the human body how to make proteins that triggers an immune response against an invading virus AND it is now known that it can protect against a variety of infectious diseases and even cancers. Very little of this was known back in 2017 but today is it is resoundingly clear!
The "take away"
RGBP has the same mRNA biotechnology in its Patent portfolio that today is already in the process of advancing into FDA Approved Clinical Trials via Oncology Pharma for treating pancreatic & colon cancer.
What few investors realize is the direction this is transitioning toward is the Immuno-Oncology Global Market along side many of the Major Big Phama players I previously identified on the link below:
https://www.ventureradar.com/keyword/Cancer%20Vaccines
Each of RGBP's Patents are "advanced science based" and represent Disruptive Biotechnology. Each one is worth Billions and combined easily have a Trillion Dollar market capacity.
The mRNA Cancer Vaccine Market itself is a Trillion Dollar Market that the Big Pharmas listed on the above link are aggressively moving toward and so is RGBP!
With this said, it is a natural instinct of Big Pharmas to ACQUIRE cutting edge Biotechnology to expand their foot print in the Global Market which is what Gilead Sciences did in 2017 when they acquire Kite for nearly $12 Billion to obtain the only Patent Kite had at that time that was mRNA based for treating various cancers. The Kite scientists were on the cutting edge of this and look where we are today only 4 year later where many Big Pharmas are aggressively pursuing the Immuno-Oncology cancer vaccine prospect.
Based on this, and based on what is known TODAY about the Power of mRNA vaccine Biotechnology to modify immune transcription responses relative to viruses that is now extending to include its application for treating infectious diseases and cancers, it's just a matter of time before RGBP is bought out by a Big Pharma in order to fast track themself to carving out a portion of that global mRNA vaccine market sector and it will likely occur via a BIDDING WAR to ACQUIRE RGBP!!!
This would be consistent with the 8K Dr. Koos filed on 4/27/21 to prevent a Hostile Take Over by Big Pharmas seeking to ACQUIRE RBGP and it's very clear to me as a clinical trials physician based on what I know about the behavior & mentality of Big Pharmas, there's going to be an aggressive pursuit to acquire this company. WHY? Like I've said before....control of market share is what it's ALL about AT ANY COST and by any means necessary where MONEY is no obstacle!
This is the vicious and highly aggressive nature of the Big Pharma industry as a whole that I've previously discussed and unless you understand this, a Bidding War over RGBP won't make sense and I'm NOT saying it will definitely happen, but it is highly likely and if not then you have to ask yourself why did Dr. Koos file that 8K on 4/27/21?
Best wishes to all...
Be well and prosper...
Well Said!
100% CORRECT!
....and that extends to POST September 21, 2021 when there will be a dramatic REDUCTION in OTC Stocks by at least 5,000 due to Non Sec Compliance! Presently there are at least 10,000.
Money will naturally flow into Stocks that have a real business operation, revenues or prospect of revenues, innovative products & services, and a high market capacity! This will apply to less than 5% of all remaining stocks IF that many.
ALL investors are drawn to VALUE and the prospect of gains and RGBP definitely has that and A LOT more going for it.
IMO RGBP is in the Top 3 Stocks on the OTC and now that it is PINK CURRENT it will likely be the most sought after stock on the entire OTC!
It's already the #1 "Most Read" on the iHub Message Board.
Best wishes to all...
BUY OUT IMMINENT!!!
That's ultimately what Pink Current is all about and it will absolutely include a PPS EXPLOSION!!!
Here's my Top 5 Big Pharma Buyer Pick List for those who haven't seen it
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165627226
You may want to get your BUY ORDERS IN NOW for reason if you wait until Monday it will be very unlikely to get filled due to the hundreds of millions of Buy Orders coming in from all over the world!
This is the moment you've ALL been waiting for...DON'T BLOW IT!
PUT YOUR BUY ORDERS IN TODAY!!
I wouldn't at all be surprised if RGBP's run is bigger than AMG & Game Stop! Isn't finding a successful treatment for deadly cancers thereby improving the quality of people's lives more valuable than going to movie theaters or video games???
If you're in this stock and are holding a substantial number of shares, i.e. at least 100,000 you will absolutely become a Millionaire.
If you're holding at least 1 Million shares you will easily become a Multi-Millionaire sort term possibly within weeks!
LOAD NOW OR SEE A PSYCHIATRIST FOR DEPRESSION LATER!
Yep!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165627226
Be well and prosper..
It's Official! PINK CURRENT!!!
https://www.otcmarkets.com/stock/RGBP/security
GAME ON!!!
See everyone Monday!
Cheers!
Yet ANOTHER Great Post!
I'll be exceptionally happy when Koos drops the BIG BUY OUT BOMB!
Yes, And Here's That Eternal Source...
Titus 2:13
Said It Right!
Big Things coming down the Pipeline REAL SOON!!
Buy Out announcement is a very high probability!
We will see, but either way...we HOLD THE GOLD!!
Be well and prosper...
Not Bad..Not Bad At ALL! UP Yet ANOTHER 10% TODAY Near 0.07
...this makes the 9th Trading in a Row we're UP!
...and to boot with a Trading Volume North of a Quarter Billion!
... and a $Dollar Volume of $24.3 Million!
I would say things are looking darn good going into official Pink Current on Monday!!!
Blue skies from here!!!
GAME ON!!!
Sounds About Right & It Would Make Perfect Sense!
Good post!
Let's see if we can close UP today another 10-20% which it looks like we're on Tract to do just that with only 25 Minutes to go!
Oh, by the way did you notice that the current Trading Volume is North of a QUARTER BILLION AND $Dollar Volume 23.1 Million!
If NOT, GAME ON Monday FOR SURE!
Be well and prosper...
News Reports Out Everywhere Saying NASDAQ & S&P 500...
...are a RECORD HIGHS, i.e. both Insider Financial & Yahoo Finance!
...not only this, IF you haven't notice ALL the Indexes are UP across the board daily!
This is indicative of a possible Market Rotation returning to a Bull Market the last Quarter this year as the economy is in full swing recovery with Covid 19 getting under control and more people returning to work, and if so, we can expect very serious price action on stocks in all sectors from September onward!
Just food for thought!
Be well and prosper...
Well Said! I Concur 100%
As an Industry Insider I couldn't agree more with your analysis!
Like I've said before, Koos at his age and ALL the years he put into this, is very likely looking to retire ASAP with a Giant Golden Egg in his Bank Account, then spend the remainder of his years doing the things he'd like to do living off the fruits of his labor while his health is still intact.
At his age he doesn't have many "quality years" to live out which begins to rapidly diminish around Age 70 onward.
I believe retirement is front center stage in his life which IMO explains why he's rapidly pulling everything together at warp speed preparing to sell this company, and the 8K he filed on 4/27/21 is a BLARING indicator of this!
Thanks for sharing you great perspective!
Be well and prosper...
No Worries! The Fun Begins Monday w/Pink Current...
....appearing on the OTC Website!
LAST CHANCE to LOAD HEAVILY is TODAY!!
Whoever is SELLING Going Into Pink Current on Monday...
...needs their head examined!
...but I guess they need the money that likely they couldn't afford to put into the stock market which is more common than not.
Great Post!
Excellent key points and I couldn't agree more!
This is exactly what I've been discussing over the past week.
Any Big Pharma that's seriously interested in advancing their foot print in these key areas of Disruptive Biotechnology would be far better off simply acquiring RGBP. Licensing doesn't cut it for reason it's subject to time limitations AND having to pay royalties over extended periods.
Not only this any Big Pharma has the cash to easily acquire RGBP which would be a major game changer that would instantly carve out a large share of the mRNA Vaccine Market that today scores of them are aggressively working toward have a major stake in!
The reality is it would be very unwise for any Big Pharma to NOT seize the opportunity to own RGBP with all 24 of our transformative bioscience Patents that collective took more than 100 years to develop at a cost of hundreds of millions of dollars and thousands of hours of highly advance molecular research, keeping in mind that many of them today are aggressively seeking to lay claim to the mRNA Vaccine Space for reason they ALL know it's a Trillion Dollar Global Market and will absolutely define the Future of Medicine.
Like I said, it's bound to happen for reason I'm fully aware of the "Big Pharma" Industry "mentality" over the past 30+ Years as a clinical trials physician, and from my perspective like I've said before, this industry can be described as "vicious" & "cut throat" meaning any Big Pharma will go to great lengths to control market share at any cost and this is the very reason why I believe there will be a Bidding War to acquire RGBP.
I'm certain Dr. Koos has a similar perspective as I do regarding the "vicious" or "cut throat" nature of Big Pharmas and IMO he knows that a Bidding War is likely to happen which is no doubt part of the reason he filed that 8K on 4/27/21 that puts him in full control of negotiations without concern of a hostile take over resulting in him getting pushed out in the process with no voice. He knows how they are and how that can in fact happen! They are known to smile in the face of a Biopharma CEO selling their company, then turn around and stab him or her in the back and take control of the company from right under them!
Notice the word "Hostile." Ironically, this is descriptive of ALL Big Pharmas! They are EXACTLY that when it comes to controlling market share that includes acquisitions!
Again great post and thank you for sharing your perspectives.
Be well and prosper...
RGBP Will Far Exceed ENZC's Run in February: $1.50-$3.00
HERE'S WHY!
ENZC had:
#1 (1) Patent only
#2 No FDA approval
#3 No licensing arrangements
#4 No partnerships
#5 No catalysts
#6 No PR releases
#7 No prospect of revenue (due to #2 & #3)
#8 No suggestion of Buy Out by CEO
RGBP has:
#1 24 Patents worth $BILLIONS
#2 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine "The Future of Medicine"
#3 FDA Approved Patent for Clinical Trials
#4 Partnership: Received $1.1 Million from Oncology Pharma for Patent Licensing and is NOW positioned to post Quarterly Revenues for 15 YEARS! (This is indicative of a NASDAQ Stock unlike ANY OTC)
#5 Pink Current any Minute = Instant Buying World Wide!
#6 CEO suggests Buy Out by filing an 8K on 4/27/21 to protect against a Hostile Take Over that specifically states "parties seeking to ACQUIRE must negotiate directly."
#7 Big Pharmas have been identified to Acquire RGBP
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165627226
The PPS is clearly in a strong UP Trend closing UP DAILY over the past Eight (8) trading days (8/16/21 to 8/26/21) on LOW Volume with 160.5% GAINS! i.e. 0.0241 to 0.0628 respectively!
This is indicative of an IMMINENT BREAK OUT on High Trading Volume with a sharp rise in the PPS.
Post Pink Current with World Wide Buying the PPS will easily make a run to $1+...sky's the limit!
LOAD NOW!!...this may be your last chance BEFORE THE PPS BREAK OUT EXPLOSION!!!
Best wishes to all...
Another 20% Gain Today On Moderate Above Average Volume!
...closing above 0.06 with ALL Three (3) Market Indexes DOWN across the board all day!
So AGAIN, just imagine what's going to happen Post Pink Current with World Wide Buying!
Cheers!
Be well and prosper...
Isn't It Interesting RGBP is Rising DAILY On Below Average Volume!
What does that tell ya??
Now just imagine what's going to happen Post-Pink Current when MASSIVE BUY VOLUME sets in World Wide!!
$1+ easily for starters!
Be well and prosper...
Amen! You Got That RIGHT!!!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165627226
Be well and prosper...
Rising AGAIN on Below Average Volume!
10% Gain again approaching 0.06!
Consistent trend has been established since last Friday!
IMO there has been a MM reversal in releasing their stranglehold on this stock, and possibly buying it! That would be the only reason why they Naked Short Sold Counterfeit Shares to bottom out the PPS only to at some point to turn around and BUY then SELL at the top of the run to make Multi-Millions of $$$. That's what their "game" is all about. To shake investors out of their shares, then buy the same shares they sold and then let it run to the top then Sell for MASSIVE GAINS!!!
Excellent Post!
I totally agree with everything you stated in particular your mention of a Bidding War for RGBP.
It's interesting you mentioned this for reason I just completed updating my recent post about the Top 5 Big Pharmas that might acquire RGBP and I mentioned a possible Bidding War and also I revised my estimated of the possible Buy Out Price, i.e. $5.75 to $6.25 per Share OR $21.7 Billion to $23.6 Billion.
My reason for this estimate range is Gilead bought Kite for nearly $12 Billion to acquire the only Patent they had at that time in 2017 which of course was an mRNA based for treating various cancers.
My thought is since Gilead was willing to shell out that kind of money over a single mRNA patent when at that time when little was know about it, today ALL Big Pharmas industry wide are well aware of the extraordinary value of this class of Patent based on the global success of the current mRNA Vaccine for Covid-19 that was recently FDA approved, and the Market Value of this class of Patent is absolutely enormous.
RGBP's Patent Portfolio of 24 Disruptive Biotechnology Patents that includes mRNA science would definitely have a perceived Market Value far beyond the $12 Billion Gilead paid Kite in 2017. $3.50 per share that I also considered would be low ball pricing that doesn't take into consideration all 24 of RGBP's Patents of which each have a Billion Dollar Market Capacity.
You are spot on however in the higher buy out estimate, only I believe now it will be higher!
Thanks again for the great post!
Here's the link for my revised post on the Top 5 Big Pharmas that may acquire RGBP:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165627226
I would appreciate your feedback after you review my revised post.
Thank you-
Be well and prosper...
Good Question
Any answer I or anyone else would give to your question would be purely speculative.
Time frames like that are anyone's guess.
Top 5 Big Pharmas That Might Acquire RGBP (update)
I will begin this discussion with the direct quote from RGBP's CEO Dr. Koos 8-K filing on 4/27/21 where he specifically states on Page 2 the following:
Quote
"To the extent that the Non-Convertible Series NC Preferred Stock may have Anti-Takeover Effects, Regen believes that the ability of Regen to issue shares with such voting power will encourage persons seeking to ACQUIRE Regen to negotiate directly with the Board of Directors enabling the Board of Directors to consider the proposed transaction in a manner that best serves the stockholders’ interests."
https://www.otcmarkets.com/filing/conv_pdf?id=14894907&guid=yVn1ke4vP1Wve8h
The language Koos is using here is in reference to himself who due to the issuing of Preferred Stock arrangements that give him sole Voting Power and therefore exclusive control over RGBP as the head of the Board of Directors. What this means is that any Big Pharma seeking to acquire RGBP can NOT go around him to the share holders to negotiate offers to acquire the company which the share holders as a whole would decide, thus a "Hostile Take Over." With this arrangement only Koos can decide what offers to accept or not accept on his terms alone thereby putting him in full control.
List of Potential Acquiring Big Pharmas
I have listed these in the order of the highest probability from the top down and have provided a brief discussion on each of why I believe these Big Pharmas would be interested in acquiring RGBP. This is based on my professional opinion as a clinical trials physician with over 30+ Years history as a Principal Investigator who designed and managed the conduct of patient based clinical trials for Big Pharma's FDA approved Candidate Drug Patents.
The pharmaceutical companies I listed have one thing in common, they are among the Big Pharmas that have positioned themselves in the mRNA Vaccine Space that includes developing Cancer Vaccines.
I provided a link at the end of this discussion that shows the Top mRNA Cancer Vaccine Pharmaceutical Companies in the world at the present time.
#1
Gilead Sciences
Market Cap: $91.2 Billion
PPS: $ 72.80
Gilead Sciences acquired Kite Pharma in 2017 for $11.9 Billion Cash to add mRNA Vaccine Biotechnology to their therapeutic portfolio. This is a classic move many Big Pharms are known to make to expand their footprint in the pharmaceutical market place.
This single move positioned this company as a "first comer" in this transformative area of "Novel Therapeutic BioTechnology" that has the capacity to reshape Modern Medicine for treatment of serious diseases that historically respond poorly to conventional therapies. For those of you who aren't familiar with this term it's in reference to pioneering development of new drug therapies that have the capacity to exponentially increase treatment efficiency with substantially improved clinical outcomes and quality of life.
As a Clinical Trials Physician with more than 30+ years experience working in the pharmaceutical industry bringing candidate drug patents to market, I am introducing you to concepts from the Big Pharma world revealing what they ALL seek to achieve at any financial cost or otherwise, and the fact that Gilead was willing to pay Kite Pharma nearly $12 Billion to acquire their mRNA Vaccine Patent for treating various cancers should cause a light to come on in your perception of how Big Pharms think and what they're willing to do to stay ahead of the competition which is extraordinarily fierce.
Just think, Gilead took the chance to acquire Kite's Patent for BILLIONS when little was known in 2017 about mRNA Biotechnology, not knowing IF it would pan out in clinical trials and reach Market, but yet they shelled out that kind of money with insight from their scientific leadership that it was a significant "probability" it would, but yet they took the gamble anyway and it paid off in spades. This acquisition dramatically strengthened Gilead's Global market position and made them a serious player in the revolutionary mRNA Vaccine space. This represented one of the most significant advancements in modern medicine that scores of other Pharmaceutical companies since then are moving aggressively toward to carve out a place in this niche market.
My perception is Gilead would definitely be interested in acquiring RGBP in order to not only expand their foot print in the mRNA Vaccine Biotechnology space but also other areas of Novel Therapeutics based on the 24 Candidate Drug Patents RGBP has in their portfolio.
IMO if Gilead acquires RGBP that would very possibly put them on track to be named among the Top 10 Pharmaceutical Companies in the world based on Annual Revenues. Currently their annual revenues are between $24 to $26 Billion as of 2020-21. They will need to double their revenues to make it into the Top Ten, and my perception is by them controlling more Patents in the mRNA vaccine space and also expanding their Biotechnology by developing RGBP's Patents they could very possibly accomplish this, but first they need to control more of the rapidly expanding mRNA Vaccine Market and acquiring RGBP is the "fast track" for that to happen. What the average person doesn't realize is this market is expanding exponentially in the wake of the Covid-19 mRNA vaccine coming to Market."
Some of you may recall that in one of my previous posts I characterized the Big Pharma industry as "cut throat" & "vicious" meaning Big Pharma companies will do whatever is necessary to gain control of market share in their respective markets, and that motive is by any means necessary where money is no obstacle. The single best example of this is Gilead acquiring Kite in 2017 shelling out $12 Billion for Kite's one (1) mRNA Vaccine Patent when little was known about it, and if a Big Pharma doesn't have billions in cash to do this they are known to form partnerships with other Big Pharmas to acquire Patents then share in the development cost and market revenues.
IMO, there will be several Big Pharmas in line, if not already, seeking to acquire RGBP and Dr. Koss is possibly in negotiations for the best deal for the sale of this company.
#2
Precigen
Market Cap:$1.2 Billion
PPS: $5.60
As most know the CEO of Precigen, Helen Sabzevari, was previously on RGBP's scientific advisory board and the company is in the Cancer-Oncology mRNA vaccine space the same as RGBP. IMO, it would behoove Precigen to acquire RGBP for the same reasons I described for Gilead.
Key Point: Keep in mind that in the Pharmaceutical Industry it's all about Control of Market Share based on independently developed and/or acquired Biotechnology and those Patents coming to Market. This is the cornerstone of what drives this Market.
Precigen acquiring RGBP would be a strategic move IF they're interested in strengthening their Market position and simultaneously not allowing RGBP's Disruptive Biotechnology Patents to be acquire by a competitor.
#3
Pfizer
Market Cap: $275 Billion
PPS: $49.25
We know that RGBP has had a prior collaborative arrangement with a Pfizer scientist in the development of their biotechnology. We also know that Pfizer is now a world leader in the mRNA vaccine space relative to Covid-19. Common sense dictates that they would seek to diversify their footprint into the cancer-oncology mRNA vaccine space to capture a substantial share of that Market which of course is a Multi-Billion dollar market no different than the Covid-19 mRNA vaccine space. They will need RGBP's current FDA approved Patent that's about to enter clinical trials to fast track themselves in that direction. This is based on basic common sense and they have the cash to acquire RGBP easily.
#4
Moderna
Market Cap: $154 Billion
PPS: $382
This Pharma like Pfizer has had great success in the mRNA Covid vaccine space and like Pfizer they need to move swiftly to diversify their Market position by expanding it to include an mRNA Vaccine for treating various forms of cancer. My understanding is that both Pfizer & Moderna are already moving in that direction and by acquiring RGBP, Moderna would benefit the most by needing to expand their therapeutic footprint thereby diversifying their market position and them moving into the oncology-immunology space with an mRNA cancer vaccine by acquiring RGBP would put them on the fast track in that direction AND they would benefit the most as a young company to own ALL 24 of RGBP's Patents that they can place in their clinical trials pipeline.
Due to their great success in the mRNA Covid Vaccine market that resulted in a dramatic rise in their PPS from the $20 range last year to nearly $500 this year, they definitely have the financial resources to acquire RGBP. Acquiring RGBP would be fundamentally transformative to this company and make them a major contender in the mRNA vaccine space as it relates to market diversification that ALL Big Pharmas seek.
#5
BioNTech
Market Cap: $85 Billion
PPS: $350
BioNTech is a German based Pharma trading on NASDAQ under the symbol BNTX. It was founded in 2008 and is considered to be a "New Technologies Next Generation Immunotherapy Company" developing novel therapies for various cancers and other serious diseases.
The Company has a wide range of discovery therapeutic platforms for the rapid development of novel biopharmaceutical Patents. It has a broad portfolio of oncology patent drug candidates that include individualized cancer type specific mRNA-based therapies, innovative chimeric antigen receptor T cells, bispecific checkpoint immuno-modulators, targeted cancer antibodies, and small molecules. Their approach to immuno-oncology drug discover is profound, highly advanced, rapid, and wide range.
The company has broad expertise in mRNA vaccine development and in-house manufacturing capacity. BioNTech has a myriad of Big Pharma collaborators for developing multiple mRNA vaccine candidates that includes targeting wide range of infectious diseases alongside its diverse oncology pipeline. It's Big Pharma collaborator/partnerships include Sanofi, Bayer, Genentech, Roche, Regeneron, and Pfizer.
This company is a prime example of how Big Pharmas aggressively form partnership arrangements with other Big Pharma players in order to fast track their scientific discoveries relative to developing novel candidate drug patents and leverage gaining market share much faster than if they were to go it alone.
This key point makes RGBP a prime candidate for acquisition by this company, not only to gain important scientific I.P. insights that can further their own candidate drug development prospects, but also ADD to placing drug patents instantly into their clinical trials pipeline that RGBP developed. Not only this, they have an extensive clinical trials pipeline infrastructure in house.
Here's the link to their company website
https://investors.biontech.de/news-releases/news-release-details/biontech-announces-first-patient-dosed-phase-2-clinical-trial
Link to the TOP mRNA Cancer Vaccines Pharmas in the world
https://www.ventureradar.com/keyword/Cancer%20Vaccines
It is my hope that the information I provided in my discussion serves many of you in your decision making about investing in RGBP and also builds confidence that you're in the right place at the right time.
Just know that the Patents RGBP has are absolutely worth Billions and there are many Big Pharmas who would substantially benefit from acquiring them not only to gain scientific insight into their own drug development processes, but also afford them with the luxury of placing many of RBGP drug Patents immediately into their clinical trials pipeline which is the "fast track" to any of them gaining Market share, keeping in mind that each of these Patents cost Millions to develop, required thousands of hours of scientific bench work, and many years or decades to develop.
Lastly, if a Buy Out/Acquisition occurs it will NOT be based alone on RGBP's current share price. It will be based on the perceived Market Value of this Company that includes ALL 24 of its Patents including the mRNA candidate drug patent for treating pancreatic and colon cancer that's presently entering clinical trials via Oncology Pharma.
Again as a reminder keep in mind Gilead acquired Kite in 2017 for nearly $12 Billion to obtain the ONLY Patent the company had at that time, i.e. it's disruptive biotechnology industry changing mRNA Vaccine Patent that in general is presently causing a paradigm shift in the practice of Modern Medicine! It is in fact defining the Future of Medicine.
I believe if RGBP is acquired it will be between $5.75 to $6.25 per Share (i.e. $21.7 Billion to $23.6 Billion), and with this it's important to keep in mind that the value of anything is based on what someone is willing to pay for it. NOTE: This is a revision of my prior estimate after taking into consideration that I strongly believe a "Bidding War" will take place over RGBP.
It's important to recognize that based on Gilead's Sciences acquisition of Kite this was based entirely on the mRNA Cancer Vaccine Patent Kite developed relative to its future global market potential, plus a premium on the prevailing share price at the time of acquisition, and again this was at a time when little was known about mRNA Biotechnology unlike today where everyone in the Industry knows about it and is highly motivated to carve out a piece of that Market in order to remain competitive in the rapidly advancing pharmaceutical landscape that's on the brink of radical transformation in medical therapeutics that will define the future of medicine. i.e. cures for cancer, Aids/HIV, and in some cases the elimination of life threatening diseases altogether.
Disclaimer: All the above is my professional opinion only based on my career experience and extensive knowledge of this industry.
Be well and prosper...
Exactly Why I Included Moderna In The Top 5 Big Pharmas
...as potential Buy Out candidates for RGBP for the very reasons listed on their company website on the link you provided!
They (Moderna) mention that they are "developing candidate patents for mRNA-based vaccines and therapies spanning several therapeutic areas", which of course extends beyond their Covid-19 mRNA Vaccine that has gone national if not global.
Moderna is also listed on the link I provided for being among the TOP Cancer mRNA Vaccine developers in the world and it just so happens that RGBP is a player in the same space which is why I believe we could be acquired by Moderna I listed in my Top 5 Big Pharma buy out candidates!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165563015
https://www.ventureradar.com/keyword/Cancer%20Vaccines
It may be prophetic that Moderna is "the company that we keep" indeed, and that might become literal via acquisition in the days ahead!
Be well and prosper...
UP Another 19.3% Gain On Moderate Volume!
I'll take that any day!
Trading Volume: 170.2 Million
Dollar Volume: $8.5 Million
Not bad...not bad at all!
Now let's continue that from here onward!
Best wishes to all...
Be well and prosper...
Heading To Close UP ANOTHER 18-20% Holding Gains!
...on slightly higher than AVERAGE Volume!
We are officially in BREAK OUT!
GREAT SIGN!!!
HA! YOU DON'T KNOW THAT!!
Yet ANOTHER Great Example!
That too is part of what happens when sudden surges in Buy Volume Occur, even IF the volume is BELOW Average!
This is an observation everyone here needs to be clear about.
We Will Sky Rocket on Massive Buy Volume Surges Post Pink Current!
I was vested in ENZC back in Feb and watch massive surges in Buy Volume for several days in a row that sent the PPS to nearly $1.00.
First it hit 0.12, then 0.15....0.25...0.35...0.52 (by then many had already become Millionaires), then it kept rising day after day to 0.65, then 0.70...0.80...and it then hit 0.95. By then several investors became Multi-Millionares and the exact same thing is about to happen with RGBP, only much greater.
Excellent point you made that needed to be mentioned.
Thanks
This Is To Prove A Point I've Mentioned Many Times!
Notice how the PPS is rising on below average volume in a "break out" mode and the reason why??
Like I've said before the MMs can't handle surges in BUY VOLUME but yet the Buy Volume so far today at mid-day is moderate and below average.
Now just imagine what's going to happen Post Pink Current when massive buy volume sets in World Wide!
This is EXACTLY how ENZC made its run in Feb to nearly $1.00 only 19 trading days after going Pink Current
RGBP is going to go much higher....$1.25 to $1.50 for starters! IMO
Be well and prosper...
Sounds Good To Me!
Great post!
Thanks!
20/20 On Forthcoming Week
What we know:
RGBP is UP 45.4% in past three trading days. UP 137% in August alone!
This past Friday closed UP 17.3% @ 0.04 with a trading volume of nearly a Quarter Billion & Dollar Volume of nearly $10 MILLION!!!
What we're looking at is a very definite upward trend that typically precedes a massive BREAK OUT and this past Friday was an exceptionally strong indicator of that!!!
Not only this Pink Current is IMMINENT and can occur any hour without warning that will result in INSTANT world wide buying!
GAME ON!!! ARE YOU PAYING ATTENTION???
Not only this a short list of the Top 5 Big Pharmas I identified here this weekend as likely candidates to ACQUIRE RGBP if that happens. This information is an opinion shared among my inner circle colleagues in the Big Pharma industry that's more than "casual speculation."
Best wishes to all...
Be well and prosper...